Dynamics of T Cell Expression of Immune Checkpoint Molecules in Progressive Multifocal Leukoencephalopathy

NARecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

February 23, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Progressive Multifocal Leukoencephalopathy
Interventions
BIOLOGICAL

Collection of blood and urine

Collection of blood (47 mL) and urine (5 mL) at PML diagnosis and 1, 3 and 6 months after, for analysis of immune checkpoint molecules expression, detection of antiviral immune responses and virological analyses.

BIOLOGICAL

Spinal tap

Spinal tap for monitoring of JC viral load at PML diagnosis and 1, 3 and 6 months after, and collection of CSF (2 mL) for virological analyses.

DIAGNOSTIC_TEST

Brain MRI

Brain MRI at at PML diagnosis and 3 and 6 months after

BIOLOGICAL

Neurological evaluation

Neurological evaluation at PML diagnosis and 1, 3 and 6 months after

Trial Locations (4)

30029

NOT_YET_RECRUITING

CHU Nimes, Nîmes

31000

RECRUITING

CHU de TOULOUSE, Toulouse

Unknown

NOT_YET_RECRUITING

CHU Bordeaux, Bordeaux

NOT_YET_RECRUITING

CHU Montpellier, Montpellier

All Listed Sponsors
lead

University Hospital, Toulouse

OTHER